Drug-mediated marrow purging: mafosfamide in adult acute leukemia in remission. The experience of the Italian study group.
Rizzoli
U
U
Cattedra di Enotologia, Parma, Italy.
Mangoni
L
L
Carella
A M
AM
Aglietta
M
M
Porcellini
A
A
Coleselli
P
P
Angrilli
F
F
Alessandrino
E P
EP
Madon
E
E
Locatelli
F
F
D000293:Adolescent; D000328:Adult; D001853:Bone Marrow / Q000473:pathology; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D002648:Child; D003520:Cyclophosphamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007223:Infant; D007558:Italy; D015470:Leukemia, Myeloid, Acute / Q000473:pathology / Q000601:surgery*; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000528:radiation effects; D011182:Postoperative Care; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology / Q000601:surgery*; D011300:Preoperative Care; D014916:Whole-Body Irradiation
C048341:mafosfamide; D003520:Cyclophosphamide; D002066:Busulfan